Altered mRNA expression due to insertion or substitution of thymine at position +3 of two splice-donor sites in the androgen receptor gene

European Journal of Human Genetics

Volumn 5, Issue 1, 1997, Pages 50-58

  Trifiro, Marka ^a,b   Lumbroso, Rose ^a   Beitel, Lenore K ^a   Vasiliou, D Marie ^a   Bouchard, Joanne ^a   Deal, Cheri ^c   Van Vliet, Guy ^c   Pinsky, Leonard ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Androgen insensitivity; Androgen receptor; Exon skipping; Insertion mutation; Splice donor site; Substitution mutation

Indexed keywords

ANDROGEN RECEPTOR; MESSENGER RNA; THYMINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CASE REPORT; EXON; GENE MUTATION; HUMAN; HUMAN CELL; INTRON; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SKIN FIBROBLAST;

EUKARYOTA;

EID: 0030909661     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1159/000484731     Document Type: Article

References (33)

1. Quigley CA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM, French FS: Androgen receptor defects: Historical, clinical, and molecular perspectives. Endocr Rev 1995;16:271-321.
2. Gottlieb B, Trifiro M, Lumbroso R, Pinsky L: The androgen receptor gene mutations database. Nucleic Acids Res 1997;25:158-162.
3. Ris-Stalpers C, Kuiper GGJM, Faber PW, Schweikert HU, van Rooij HCJ, Zegers ND, Hodgins MB, Degenhart HJ, Trapman J, Brinkmann AO: Aberrant splicing of androgen receptor mRNA results in synthesis of a nonfunctional receptor protein in a patient with androgen insensitivity. Proc Natl Acad Sci USA 1990;87:7866-7870.
4. Evans BAJ, Ismail RA, France T, Hughes IA: Analysis of the androgen receptor gene structure in a patient with complete androgen insensitivity syndrome. J Endocrinol 1991:129 (suppl):abstr 65.
5. Yong EL, Roy A, Chua KL, Ratnam S, Yang M: Complete androgen insensitivity due to a splice-site mutation in the androgen receptor gene and genetic screening with single-stranded conformation polymorphism. Fertil Steril 1994;61:856-862.
6. Hidaka Y, Palella TD, O'Toole TE, Tarlé SA, Kelley WN: Human adenine phosphoribosyltransferase: Identification of allelic mutations at the nucleotide level as a cause of complete deficiency of the enzyme. J Clin Invest 1987; 80:1409-1415.
7. Carstens RP, Fenton WA, Rosenberg LR: Identification of RNA splicing errors resulting in human ornithine transcarbamylase deficiency. Am J Hum Genet 1991;48:1105-1114.
8. De Boer M, Bolscher BGJM, Dinauer MC, Orkin SH, Smith CIE, Ahlin A, Weening RS, Roos D: Splice site mutations are a common cause of X-linked chronic granulomatous disease. Blood 1992;80:1553-1558.
9. Sankila EM, Tolvanen R, van den Hurk JAJM, Cremers FPM, de la Chapelle A: Aberrant splicing of the CHM gene is a significant cause of choroideremia. Nat Genet 1992;1:109-113.
10. Bidichandani SI, Shiach CR, Lanyon WG, Connor JM: A novel splice donor mutation affecting position +3 in intron 6 of the factor VIII gene. Hum Mol Genet 1994;3:651-653.
11. Inazu A, Jiang XC, Haraki T, Yagi K, Kamon N, Koizumi J, Mabuchi H, Takeda R, Takata K, Moriyama Y, Doi M, Tall A: Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 1994;94:1872-1882.
12. Kaler SG, Gallo LK, Proud VK, Percy AK, Mark Y, Segal NA, Goldstein DS, Homes CS, Gahl WA: Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus. Nat Genet 1994; 8:195-202.
13. Mertes G, Ludwig M, Finkelnburg B, Krawczak M, Schwaab R, Brackmann HH, Olek K: A G+3-to-T donor splice site mutation leads to skipping of exon 50 in von Willebrand factor mRNA. Genomics 1994;24:190-191.
14. Morrone A, Morreau H, Zhou XY, Zammarchi E, Kleijer WJ, Galjaard H, d'Azzo A: Insertion of a T next to the donor splice site of intron 1 causes aberrantly spliced mRNA in a case of infantile GM1-gangliosidosis. Hum Mutat 1994;3:112-120.
15. Purandare SM, Lanyon WG, Connor JM: Characterisation of inherited and sporadic mutations in neurofibromatosis type-1. Hum Mol Genet 1994;3:1109-1115.
16. Brackett JC, Sims HF, Rinaldo P, Shapiro S, Powell CK, Bennett MJ, Strauss AW: Two alpha subunit donor splice site mutations cause human trifunctional protein deficiency. J Clin Invest 1995;95:2076-2082.
17. Miyaki M, Konishi M, Muraoka M, Kikuchi-Yanoshita R, Tanaka K, Iwama T, Mori T, Koike M, Ushio K, Chiba M, Nomizu S, Utsunomiya J: Germ line mutations of hMSH2 and hMLH1 genes in Japanese families with hereditary nonpolypopsis colorectal cancer (HNPCC): Usefulness of DNA analysis for screening and diagnosis of HNPCC patients. J Mol Med 1995;73:515-520.
18. Shkolny DL, Brown TR, Punnett HH, Kaufman M, Trifiro MA, Pinsky L: Characterization of alternative amino acid substitutions at arginine 830 of the androgen receptor that cause complete androgen insensitivity in three families. Hum Mol Genet 1995;4:515-521.
19. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
20. Beitel LK, Prior L, Vasiliou DM, Gottlieb B, Kaufman M, Lumbroso R, Alvarado C, McGillivray B, Trifiro M, Pinsky L: Complete androgen insensitivity due to mutations in the probable alpha-helical segments of the DNA-binding domain in the human androgen receptor. Hum Mol Genet 1994;3:21-27.
21. Lubahn DB, Joseph DR, Sar M, Tan J, Higgs HN, Larson RE, French FS, Wilson EM: The human androgen receptor: Complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 1988;2:1265-1275.
22. Trifiro M, Prior RL, Sabbaghian N, Pinsky L, Kaufman M, Nylen EG, Belsham DD, Greenberg CR, Wrogemann K: An amber mutation creates a diagnostic MaeI site in the androgen receptor gene of family with complete androgen insensitivity. Am J Hum Genet 1991;40: 493-499.
23. Kazemi-Esfarjani P, Beitel LK, Trifiro M, Kaufman M, Rennie P, Sheppard P, Matusik R, Pinsky L: Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes. Mol Endocrinol 1993;7:37-46.
24. Zegers ND, Claassen E, Neelan C, Mulder E, van Laar JH, Voorhorst MM, Berrevoets CA, Brinkmann AO, van der Kwast TH, Ruizeveld de Winter JA, Trapman J, Boersma WJA: Epitope prediction and confirmation for the human androgen receptor Generation of monoclonal antibodies for multi-assay performance following the synthetic peptide strategy. Biochim Biophys Acta 1991;1073:23-32.
25. Shapiro MB, Senapathy P: RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression. Nucleic Acids Res 1987;15: 7155-7174.
26. Cooper DN, Krawczak M: Human Gene Mutation. Aransas Pass/Tex, BIOS Scientific Publishers, 1993.
27. Nakai K, Sakamoto H: Construction of a novel database containing aberrant splicing mutations of mammalian genes. Gene 1994;141: 171-177.
28. Ris-Stalpers C, Verleun-Mooijman MC, de Blaeij TJ, Degenhart HJ, Trapman J, Brinkmann AO: Differential splicing of human androgen receptor pre-mRNA in X-linked Reifenstein syndrome, because of a deletion involving a putative branch site. Am J Hum Genet 1994;54:609-617.
29. Maruyama T, Miyake Y, Tajima S, Funahashi T, Matsuzawa Y, Yamamoto A: A single point mutation in the splice donor site of the low-density-lipoprotein-receptor gene produces intron read-through, exon-skipped and crypticsite-utilized transcripts. Eur J Biochem 1995; 232:700-705.
30. Horowitz DS, Krainer AR: Mechanisms for selecting 5′ splice sites in mammalian pre-mRNA splicing. Trends Genet 1994;10:100-106.
31. Robberson BL, Cote GJ, Berget SM: Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol Cell Biol 1990; 10:84-94.
32. McIntosh I, Hamosh A, Dietz HC: Nonsense mutations and diminished mRNA levels. Nat Genet 1993;4:219.
33. Lim SK, Sigmund CD, Gross KW, Maquat LE: Nonsense codons in human β-globin mRNA result in the production of mRNA degradation products. Mol Cell Biol 1992;12:1149-1161.